Keros Therapeutics, Inc. (KROS) Insider Trading

Name: Keros Therapeutics, Inc. (KROS) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Aug 20, 2026): Tanini Annita (Corp. Controller & VP, Finance): Sale of 1,224 shares, $12.6K.

Get alerted when insiders trade KROS

Email address

Loading company data...

Loading company details...